Antibodies to Phosphorylated IRAK4
    8.
    发明申请
    Antibodies to Phosphorylated IRAK4 审中-公开
    磷酸化IRAK4的抗体

    公开(公告)号:US20100279316A1

    公开(公告)日:2010-11-04

    申请号:US12523681

    申请日:2008-01-09

    摘要: The present invention relates to antibodies that bind phosphorylated forms of IRAK4, methods of using such antibodies to detect IRAK4 biological activity, and methods for the detection, diagnosis, and prognostication of pathological conditions related to IRAK4 biological activity. ERAK4 is one member of a small family of highly conserved cytoplasmic signal transduction proteins characterized by the presence of an N-terminal “death domain” and a C-terminal serine-threonine kinase domain. IRAK4 functions in cytoplasmic signal transduction pathways by interacting with membrane spanning proteins which play, inter alia, critical roles in vertebrate immune system function.

    摘要翻译: 本发明涉及结合IRAK4的磷酸化形式的抗体,使用这种抗体检测IRAK4生物活性的方法,以及用于检测,诊断和预测与IRAK4生物活性有关的病理学病症的方法。 ERAK4是一种高度保守的细胞质信号转导蛋白家族的成员,其特征在于存在N末端“死亡结构域”和C末端丝氨酸 - 苏氨酸激酶结构域。 IRAK4通过与膜跨膜蛋白相互作用而在细胞质信号转导途径中起作用,尤其是在脊椎动物免疫系统功能中起关键作用。